Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin.

Abstract

AIM To evaluate cases of deep vein thrombosis (DVT) and pulmonary embolism (PE) reported in a prescription event monitoring study of Yasmin, an oral contraceptive. METHODS Reports of DVT/PE and events suggestive of DVT/PE were followed up by questionnaire. RESULTS Thirteen cases (DVT five; PE eight), each with possible risk factor(s), were identified in… (More)

Topics

Cite this paper

@article{Pearce2005DeepVT, title={Deep vein thrombosis and pulmonary embolism reported in the Prescription Event Monitoring Study of Yasmin.}, author={Hilary M Pearce and Deborah Layton and Lynda V. Wilton and Saad A. W. Shakir}, journal={British journal of clinical pharmacology}, year={2005}, volume={60 1}, pages={98-102} }